Latest filing published 07 Sept 2022 for Newbury Pharmaceuticals AB, €2,617.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -8.2%Entry SEK 4.16 · Close at T+365 SEK 3.82
- -54.0%Entry SEK 12.60 · Close at T+365 SEK 5.80
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Lars Minor: trading record in brief
This profile gathers the share dealings of Lars Minor in Newbury Pharmaceuticals AB. The record holds 2 filings, for trades running from 27 January 2022 to 6 September 2022.
Every open-market trade on record is a purchase: 2 purchases worth €22k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The newest entry dates from 7 September 2022: an open-market purchase of €2,617, in Newbury Pharmaceuticals AB. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Companies and markets linked to Lars Minor
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,000 shares@ SEK 4.001512.0% of flowAktieISIN SE0015244884FI:csv-1a13e18fbf1b6aeafffcCanonical exit: 5 Dec 2022 (T+90)
- 15,385 shares@ SEK 13.0088.0% of flowAktieISIN SE0015244884FI:csv-0e64569a173be94f315bCanonical exit: 27 Apr 2022 (T+90)
2 of 2 declarations